We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA’s Obesity Working Group (OWG) has told the agency it should update an 8-year-old draft guidance on weight loss drugs to address newer long-term therapies and to advance an HHS campaign to alleviate the obesity epidemic in the U.S.